Valeo Pharma Inc.
OTC: VPHIF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Kyle Steiger
- Employees
- 70
- Headquarters
- Kirkland, Canada
- IPO year
- 2020
- Market cap
- $9.9K
- Website
- https://www.valeopharma.com
Loading VPHIF…
Loading profile data…Frequently asked questions about VPHIF
What does Valeo Pharma Inc. (VPHIF) do?
Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to sourcing, licensing, and selling a variety of medicinal products, with a primary emphasis on respiratory, specialized, and hospital-grade generic drugs. Its extensive product lineup features prominent asthma medications like Enerzair Breezhaler (a triple-combination LABA/...
Where does VPHIF trade?
Valeo Pharma Inc. (VPHIF) trades on the Other OTC.
What sector is VPHIF in?
Valeo Pharma Inc. (VPHIF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Valeo Pharma Inc.?
Kyle Steiger is the chief executive officer of Valeo Pharma Inc. (VPHIF).
Where is Valeo Pharma Inc. headquartered?
Valeo Pharma Inc. is headquartered in Canada.
Does VPHIF pay a dividend?
Valeo Pharma Inc. (VPHIF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VPHIF go public?
Valeo Pharma Inc. (VPHIF) completed its initial public offering in 2020.